Literature DB >> 23385275

Opioid analgesics for rheumatoid arthritis pain.

Samuel L Whittle1, Bethan L Richards, Rachelle Buchbinder.   

Abstract

CLINICAL QUESTION Do the benefits of opioid analgesics outweigh the risks in patients with persistent pain due to rheumatoid arthritis? BOTTOM LINE Weak opioids (such as codeine, dextropropoxyphene, and tramadol) may be effective in the short-term management of rheumatoid arthritis pain, but adverse effects are common and may outweigh the benefits; alternative analgesics should be considered first.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23385275     DOI： 10.1001/jama.2012.193412

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  9 in total

1.  Opioid prescribing is a surrogate for inadequate pain management resources.

Authors:  Hillel M Finestone; David N Juurlink; Barry Power; Tara Gomes; Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2016-06       Impact factor: 3.275

2.  [La prescription d'opioïdes: un substitut au manque de ressources en contrôle de la douleur].

Authors:  Hillel M Finestone; David N Juurlink; Barry Power; Tara Gomes; Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2016-06       Impact factor: 3.275

3.  Dorsal Root Ganglion Stimulation Alleviates Pain-related Behaviors in Rats with Nerve Injury and Osteoarthritis.

Authors:  Guoliang Yu; Ian Segel; Zhiyong Zhang; Quinn H Hogan; Bin Pan
Journal:  Anesthesiology       Date:  2020-08       Impact factor: 7.892

4.  Evaluation of opioid use among patients with back disorders and arthritis.

Authors:  Corey J Hayes; Nalin Payakachat; Chenghui Li
Journal:  Qual Life Res       Date:  2018-07-23       Impact factor: 4.147

Review 5.  Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.

Authors:  Christine Anastasiou; Jinoos Yazdany
Journal:  Curr Opin Rheumatol       Date:  2022-03-01       Impact factor: 5.006

6.  Pain-novel targets and new technologies.

Authors:  Susan Hua; Peter J Cabot
Journal:  Front Pharmacol       Date:  2014-09-16       Impact factor: 5.810

7.  Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation.

Authors:  Yanqiong Zhang; Ming Bai; Bo Zhang; Chunfang Liu; Qiuyan Guo; Yanqun Sun; Danhua Wang; Chao Wang; Yini Jiang; Na Lin; Shao Li
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

8.  Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis.

Authors:  Susan Hua; Thilani H Dias; Debbie-Gai Pepperall; Yuan Yang
Journal:  Front Pharmacol       Date:  2017-08-02       Impact factor: 5.810

9.  Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis.

Authors:  Siyeon Park; Tham T Le; Julia F Slejko; Ester Villalonga-Olives; Eberechukwu Onukwugha
Journal:  Rheumatol Ther       Date:  2019-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.